• If you are wondering whether Elevance Health's current share price offers good value or not, it helps to look past the headlines and focus on what the numbers are saying.
• The stock last closed at US$345.74, with returns of a 6.8% decline over 7 days, a 2.4% decline over 30 days, a 2.4% decline year to date, and a 10.9% decline over 1 year, while the 5 year return sits at 27.2%.
• Recent news around Elevance Health has centered on broader healthcare policy discussions and insurer sentiment, which can influence how investors think about long term profitability and pricing power. That context helps explain why the stock's shorter term returns differ from its longer term performance, as the market reassesses risk and potential rewards.
• On our valuation checks, Elevance Health scores 5 out of 6, and you can see the detailed breakdown in our valuation score of 5, which we will unpack using several valuation approaches before turning to an even more helpful way to think about what the stock might be worth.

Approach 1: Elevance Health Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s value using a required rate of return. The idea is simple: what matters is the cash the business is expected to generate over time, expressed in today’s dollars.

For Elevance Health, the latest twelve month free cash flow sits at about $2.96b. Using a 2 Stage Free Cash Flow to Equity model, analysts have provided explicit forecasts for several years, then Simply Wall St extrapolates further out. By 2030, projected free cash flow is $8.59b, with annual projections between 2026 and 2035 ranging from roughly $5.30b to $11.58b before discounting.

When all of those discounted cash flows are added together, the model arrives at an estimated intrinsic value of about $1,004.53 per share. Compared with the recent share price of $345.74, this implies the stock is 65.6% undervalued according to this DCF framework.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Elevance Health is undervalued by 65.6%. Track this in your watchlist or portfolio, or discover 875 more undervalued stocks based on cash flows.

Approach 2: Elevance Health Price vs Earnings

For a consistently profitable company, the P/E ratio is a straightforward way to think about what you are paying for each dollar of earnings. Investors usually accept a higher P/E when they expect stronger earnings growth or see the business as lower risk, and a lower P/E when they expect slower growth or see more risk.

Elevance Health currently trades on a P/E of 13.57x. That sits below both the Healthcare industry average P/E of about 21.98x and the peer average of 22.09x. On the surface, that points to the market applying a lower earnings multiple than it does for many other healthcare names.

Simply Wall St’s Fair Ratio for Elevance Health is 31.48x. This is a proprietary view of what the P/E could be, given factors such as the company’s earnings growth profile, industry, profit margins, market cap and risk characteristics. Because it brings these elements together, the Fair Ratio can be more tailored than a simple comparison with industry or peer averages, which do not adjust for company specific strengths or weaknesses. Set against the current P/E of 13.57x, the Fair Ratio suggests the shares are trading below that implied level.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1426 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Elevance Health Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. These give you a simple story behind the numbers such as your fair value, and your assumptions for Elevance Health’s future revenue, earnings and margins.

A Narrative links what you believe about a company to a forecast, and then to a fair value that you can compare with today’s share price to decide whether the gap between value and price looks appealing to you.

On Simply Wall St, Narratives sit inside the Community page and are designed to be easy to use. You can adjust assumptions, see the fair value update instantly, and check how your view compares with what millions of other investors are thinking.

Narratives are also refreshed when new information such as news or earnings is added. For Elevance Health, that means one investor might build a Narrative that points to a much higher fair value while another uses more cautious assumptions that result in a far lower figure.

Do you think there's more to the story for Elevance Health? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.